Co-Diagnostics, Inc.
CODX
$1.55
$0.021.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -337.35% | 23.85% | -2.61% | 31.71% | -13.76% |
| Total Depreciation and Amortization | 0.07% | -8.24% | 3.92% | -21.48% | 1.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,755.87% | 60.72% | 277.32% | -124.46% | -18.83% |
| Change in Net Operating Assets | 111.77% | 32.46% | 12.07% | -176.21% | 39.87% |
| Cash from Operations | -4.99% | 28.76% | 5.23% | -6.25% | -13.85% |
| Capital Expenditure | -75.77% | 81.28% | -336.45% | -25.89% | 58.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -108.78% | -87.12% | 134.56% | 2,097.32% | -92.19% |
| Cash from Investing | -115.15% | -87.26% | 132.04% | 2,665.79% | -93.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 71.72% | 846.04% | 20.95% | 241.39% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 71.72% | 846.04% | 20.95% | 241.39% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.03% | -96.43% | 991.35% | 86.85% | -156.80% |